<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Medina, C</style></author><author><style face="normal" font="default" size="100%">Santos-Martinez, M J</style></author><author><style face="normal" font="default" size="100%">Radomski, A</style></author><author><style face="normal" font="default" size="100%">Corrigan, O I</style></author><author><style face="normal" font="default" size="100%">Radomski, M W</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Nanoparticles: pharmacological and toxicological significance.</style></title><secondary-title><style face="normal" font="default" size="100%">British journal of pharmacology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Br. J. Pharmacol.</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">03/2007</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">150</style></volume><pages><style face="normal" font="default" size="100%">552-8</style></pages><language><style face="normal" font="default" size="100%">English </style></language><abstract><style face="normal" font="default" size="100%">Article reviews current developments in the use of nanoparticles in pharmacology and therapeutics, the classes of nanoparticles being used, and the demonstrated and potential toxicity of these nanoparticles.  </style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/17245366?dopt=Abstract</style></custom1></record></records></xml>